Screener
Heron Therapeutics HRTX Q4 2025 Annual earnings
Reported February 26, 2026 · Before market open
Revenue$40.6MBeat by $721.3K
EPS-$0.02Beat by $0.01
Revenue estimate$39.9M
EPS estimate-$0.03
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$37.5M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Heron Therapeutics report Q4 2025 earnings?
- Heron Therapeutics (HRTX) reported Q4 2025 earnings on February 26, 2026 before market open.
- What were Heron Therapeutics's Q4 2025 revenue and EPS?
- Heron Therapeutics reported revenue of $40.6M and eps of $-0.02 for Q4 2025.
- Did Heron Therapeutics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $39.9M by $721.3K. EPS beat the consensus estimate of $-0.03 by $0.01.
- How did Heron Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.5% from $40.8M a year earlier.
- Where can I find Heron Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-073502) and the 10-K periodic report (0001193125-26-073515) directly on SEC EDGAR. The filing index links above go to sec.gov.
